Tixagevimab Plus Cilgavimab Does Not Affect the Interpretation of Electrophoretic and Free Light Chain Assays.
Vandana BalodaErin K McCrearyBreana K GoscickiMichael R ShurinSarah E WheelerPublished in: American journal of clinical pathology (2022)
This study indicates that T + C at pharmacologic Cmax is unlikely to interfere with SPE, IFE, sFLC, or IgG1 analyses when spiked into patient serum samples, but further evaluation of recently injected patients may be warranted.